Who gets expensive cancer drugs? A tale of 2 nations

The well-worn notion that patients in the United States have unfettered access to the most expensive cancer drugs while the United Kingdom's nationalized health care system regularly denies access to some high-cost treatments needs rethinking, a team of bioethicists and health policy experts says in a report out today.

Read the whole article on Physorg

More from Physorg